Jane H. Hsiao Ph.D., MBA — Vice Chairman and Chief Technical Officer at Opko Health

Dr. Jane H. Hsiao, Ph.D., MBA, has been an Interim Chief Executive Officer of Non-Invasive Monitoring Systems Inc., since February 28, 2012. Dr. Hsiao has been the Chief Technical Officer of Opko Health, Inc. since May 2007. She serves as Investment Officer at Frost Group, LLC. She was the Founder at Innotech Laboratory in 1981 and IVAX LLC in 1986. She served as the President of Ophthalmic Technologies, Inc. She served as the Chief Technical Officer at IVAX LLC since July 1996. She serves as a Director of Acuity Pharmaceuticals Inc., Fabrus, LLC, Cocrystal Discovery, Inc. and Froptix Corporation. She has been the Vice Chairman of Opko Health Inc. since May 2007. She has been the Chairman of Non-Invasive Monitoring Systems Inc. since October 2008; and Cellular Technical Services Co. Inc. since September 5, 2007. She served as the Chairman of SafeStitch Medical, Inc. ince September 5, 2007. She is the Vice Chairman of Technical Affairs, Director, Member of Regulatory Compliance Committee, Chairman of DVM Pharmaceuticals Inc., Chief Executive Officer of DVM Pharmaceuticals Inc., President of DVM Pharmaceuticals Inc., Director of IVAX Diagnostics Inc. and Director of DVM Pharmaceuticals Inc at IVAX LLC. She has been a Director of Protalix Ltd. since August 2006; Opko Health Inc. since 2007; OPKO Biologics since May 2007; Non-Invasive Monitoring Systems Inc. since October 2008 and Cellular Technical Services Company, Inc. since September 5, 2007. She served as the Chief Executive Officer and President of DVM Pharmaceuticals Inc., IVAX' veterinary products subsidiary of IVAX LLC from March 1998 to 2006. She served as the Chief Executive Officer, President and Chief Technical Officer of IVX Animal Health. From 1992 to February 1995, she served as IVAX LLC 's Chief Regulatory Officer and Assistant to the Chairman and Vice President of Quality Assurance and Compliance of IVAX Research, Inc. From 1987 to 1992, She served as a Vice President of Quality Assurance, Quality Control and Regulatory Affairs at IVAX Research, Inc. She served as the Chairman of the Board at IVX Animal Health. She served as the Chairman of DVM Pharmaceuticals Inc. from March 1998 to 2006. She served as a Vice Chairman of IVX Animal Health. She served as a Vice Chairman-Technical Affairs and Director of IVAX LLC from 1995 to January 2006, when Teva acquired IVAX. Dr. Hsiao has been a Director of Cocrystal Pharma, Inc. since January 2, 2014. She has been a Director of TransEnterix, Inc. since 2005. She served as a Director of Medical Ventures Corp. and its Independent Director since July 1, 2008. She has been a Director of SafeStitch Medical, Inc. since April 2005. She served as a Director of Protalix Biotherapeutics Ltd. from December 31, 2006 to December 2007; IVAX Pharmaceuticals s.r.o. (Ivax-CR AS); eXegenics Inc. since February 9, 2007; Orthodontix Inc., since January 3, 2007; IVAX Corp. since 1995 and IVAX Diagnostics Inc., from 2001 to April 2006. She is a Director of Tissuetech, Inc. She served as Director of Sorrento Therapeutics, Inc. since January 2010. Dr. Hsiao received a B.S. degree in Pharmacy from the National Taiwan University and a Ph.D. degree in Pharmaceutical Chemistry and Medicinal Chemistry from the University of Illinois, Chicago in 1973. She also holds an M.B.A. degree.